Diabetes Screening for people with schizophrenia or bipolar disorder who are using antipsychotic medication (SSD) Update
| Date: | November 7, 2022 |
| To: | HPSJ Contracted Primary Care Providers and Behavioral Health Providers |
| From: | Health Plan of San Joaquin (HPSJ) |
| Subject: | Diabetes Screening for people with schizophrenia or bipolar disorder who are using antipsychotic medication (SSD) Update |
| Business: | Medi-Cal |
Managed Care Accountability Sets (MCAS) Measure
The following provides an update to the Diabetes Screening for people with Schizophrenia Bipolar Disorder Who are Using Antipsychotic Medications (SSD).
Description:
The percentage of members 18–64 years of age with schizophrenia, schizoaffective disorder, or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year.
Eligible population:
- At least one acute inpatient encounter, with any diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder
- At least two of the following:
- on different dates of service
- where both encounters have any diagnosis of schizophrenia or schizoaffective disorder or both encounters have any diagnosis of bipolar disorder
If you have questions or need assistance, please call our Provider Services team at (209) 942-6340. You may also visit https://www.hpsj.com/alerts/ for online access to the documents shared. The most recent information about Health Plan of San Joaquin and our services is always available on our website https://www.hpsj.com/.